Biopharmaceutical Projects & Resources

Adsorbed Vaccines

    Malaria Antigen Vaccines

Cell Banks

  • 2E8 Cells
  • A549 Cell Bank
  • BHK-21 Cell Bank
  • CHO Cell Bank
  • DH5 Alpha E. Coli Bank
  • HEK293 Cell Bank
  • K562 Cells
  • MRC-5 Cells
  • NS/O Cells
  • Vero Cell Bank

Immunotoxins

  • BL-22 (dsFv RFB4-PE38)
  • ERB-38
  • HA-22
  • LMB-2 (Anti-TAC Fv PE-38)
  • MR1-1 DsFv-PE38
  • RN321-RFB4 Onconase

Monoclonal Antibodies

  • 11B.11 Rat Anti Murine IL-4
  • 1D12 Anti-hu IgM
  • 2A11 Anti-Bombesin
  • 3 Antibodies, Bu 12-Saporin, 4KB128-Saporin, OKT10-Saporin
  • 7G7 Anti-IL-2 alpha R
  • 95-5-49 Anti T-cell
  • 95-6-22 Anti T-cell
  • Anti CD45RA antibody
  • Anti-transferrin scFv
  • Ch 14.18 Anti GD2
  • Ch EB6 Anti-hu IgA
  • Ch 11-1F4 Anti Ig Kappa light-chain
  • D612 Anti Colon Cancer
  • HD37 Anti CD19
  • HeFi-1 Anti CD30
  • HOKT Gamma 1 (ala, ala) Anti CD 30
  • Hu 14.18 IL-2 Fusion Protein Anti GD2
  • huATN-658 Anti uPAR
  • Hu B3 Anti Ley-carbohydrate
  • Hu HB22.7 Anti CD22
  • Hu MiK Beta 1 Anti IL2 Receptor
  • HuCC49-Delta-CH2 Anti Tag 72
  • LEC/NHS76 (PB3) Anti DNA/Histone HI-LEC fusion
  • MRK-16 Anti human P-glycoprotein
  • OVB3 Anti OVCAR-3
  • R24 Chimeric Anti GD3
  • RFB4 Anti CD22
  • VH4-34 IgM216 Anti B cell lactosamine
  • 1A7 Anti Id GD2
  • Panitumumab-IRDye800CW
  • Ganitumab IGF-1R
  • Anti-CD54

Natural Products

  • cGMP Endotoxin
  • Fumagillin
  • Geldanamycin
  • Staurosporin
  • Wortmannin

Oligonucleotides

  • GQ-ODN T40214
  • C-myb Antisense
  • IGF-1R Antisense
  • KSR Antisense
  • STAT-3 Decoy

Oncolytic Viruses

  • Ad 5/3 Delta-24
  • Ad5RGDCD/SSTR
  • Ad5RGDTK/SSTRTK
  • Ad-CCL-21
  • Ad GM-CSF-CAIX Fusion
  • AD-KD3
  • AdTSTA-sr39TK
  • Delta-24 Adenovirus Control
  • Herpes Vector Oncolytic Virus (M032, rRp450)
  • MV-NIS measles virus
  • Polio virus Chimera PVS-RIPO
  • Ad Cox-2 / RGD Tissue Specific CRAd

Plasmid Vaccines

  • pING-TYRP2
  • pNGVL4a-CRT/E7 (detox)
  • pNGVL4aNGVL4a – Sig E7 (detox)HSP70
  • Polyvalent Vaccine(JB.SF-HM8)
  • pWRG 1644
  • AFP and GMCSF plasmids (2)

Recombinant Protein

  • B7.1 Anti-Her2/neu
  • CD40 Ligand
  • Cyanovirin HIV Therapy
  • Human Recombinant IL-12
  • F-5 Cys Anti-Her2/neu scFv AB targeted Liposome
  • HPV 16 L2 E6E7 Vaccine with GPI-0100 Adjuvant
  • HSP 110/GP 100 Chaperone
  • IL-4
  • IL-6
  • Recombinant Wollinella Asparginase
  • rh IGFBP7
  • rh IL-15
  • rh IL-7 E. Coli
  • rh IL-7 Mammalian
  • RTVP-1 Protein
  • IL-2/Fc
  • Mutant IL-15/Fc
  • F1-V Plaque Vaccine
  • Mutant K-Ras Vaccines
  • PA-83 (rPA) Vaccine
  • SEB Vaccine

Synthetic Peptide

  • Novel Agent against the MUC1 oncoprotein
  • Shepherdin

Vaccine – Cellular Products

  • EBV Supernatant Vaccine
  • Pancreatic Tumor Cell Vaccine
  • Phase I/II/III Id Vaccines

Vaccine Peptide

  • Bradykinin-Antagonist Peptide
  • CAP-1 Peptide Vaccine
  • HPV 16-E7 Listeria Vaccine
  • HPV E7 Peptide Vaccine
  • Khleif Peptide Vaccines
  • MART-1 Peptide Vaccine
  • Multiple patient specific Peptide Vaccines
  • MVA-CMV
  • PADRE-CMV Vaccine
  • Tetanus-CMV Vaccine
  • PCLUS 3-18MN Peptide
  • PR103 (p53-194 His) Vaccine
  • PR24 (ras-12 Arg)
  • PR26a/p53-282-T-P
  • PR-81 Peptide
  • PR-86/p53-196Pro Peptide
  • PR92 (p53-144Arg)
  • PR95 (p53-159Pro)
  • PXFK Peptide
  • V166A-VHL-14

Viral Vaccines

  • Ad-AFP
  • Anaerobic Clostridia Spirogenes Vector
  • HSV-C134
  • VEE Vaccine